Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study

BACKGROUND: The optimal dose and fractionation scheme of stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) remains unclear due to different tolerated liver volumes and degrees of cirrhosis. In this study, we aimed to verify the dose-survival relationship to optimize dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Ting-Shi, Liu, Qiu-Hua, Zhu, Xiao-Fei, Liang, Ping, Liang, Shi-Xiong, Lai, Lin, Zhou, Ying, Huang, Yong, Cheng, Tao, Li, Le-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058965/
https://www.ncbi.nlm.nih.gov/pubmed/33882972
http://dx.doi.org/10.1186/s13014-021-01778-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058965/
https://www.ncbi.nlm.nih.gov/pubmed/33882972
http://dx.doi.org/10.1186/s13014-021-01778-6

Ejemplares similares